Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injecti... Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.98 | -1.98823290728 | 49.29 | 49.36 | 43.405 | 640693 | 45.80478377 | CS |
4 | 8.43 | 21.1384152457 | 39.88 | 51.61 | 39.365 | 1157891 | 45.18325651 | CS |
12 | 11.03 | 29.5869098712 | 37.28 | 51.61 | 35.3 | 783878 | 43.1246723 | CS |
26 | 8.53 | 21.4429361488 | 39.78 | 51.61 | 32.65 | 676245 | 40.25119477 | CS |
52 | 34.51 | 250.072463768 | 13.8 | 51.61 | 12.28 | 849441 | 37.25945417 | CS |
156 | 17.48 | 56.6980214077 | 30.83 | 51.61 | 5.2 | 518716 | 25.94313738 | CS |
260 | 36.9 | 323.400525855 | 11.41 | 51.61 | 5.2 | 449744 | 25.81249872 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約